Dow Rises 80 Points; US Jobless Claims Edge Higher
Portfolio Pulse from Lisa Levin
US stocks traded higher with the Dow Jones gaining around 80 points. Jobless claims rose by 2,000 to 204,000, lower than market expectations of 215,000. Bionomics Limited (BNOX), Baudax Bio, Inc. (BXRX), and Chico's FAS, Inc. (CHS) saw significant stock increases due to positive news, while Ascent Solar Technologies, Inc. (ASTI), Brainstorm Cell Therapeutics Inc. (BCLI), and Renalytix Plc (RNLX) experienced stock decreases due to negative news.
September 28, 2023 | 2:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bionomics Limited shares shot up 340% after the company announced positive trial results.
The company's announcement of positive trial results led to a significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Baudax Bio, Inc. shares increased by 93% after the company was granted orphan drug designation by the FDA.
The FDA's granting of orphan drug designation to the company led to a significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Chico's FAS, Inc. shares increased by 62% following the announcement of its acquisition by Sycamore Partners.
The company's announcement of its acquisition led to a significant increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Ascent Solar Technologies, Inc. shares dropped 62% after the company announced pricing of a public offering of units.
The company's announcement of a public offering led to a significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Brainstorm Cell Therapeutics Inc. shares were down 52% after the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness.
The FDA Advisory Committee's negative vote led to a significant decrease in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Renalytix Plc shares fell 31% after the company announced weak FY sales.
The company's announcement of weak FY sales led to a significant decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100